Loading...
XSHG
605266
, Last price  
Name

JZJ Chain Drugstore Corp

Chart & performance

D1W1MN
XSHG:605266 chart
P/E
—
P/S
—
EPS
1.49
Vol. 1Y
—
Shs. 5Y
5.20%
Rev. 5Y
14.84%
Div Yld LY
—
Div Yld TTM
—
Revenues
8.92b
-3.90%
1,667,138,1011,844,316,6612,053,839,9202,346,875,1682,765,851,4613,528,526,1424,466,357,3845,234,955,4187,514,444,2329,080,697,1429,282,846,1728,920,969,592
Net income
148m
+15.63%
17,350,31917,971,65870,884,72194,880,676133,625,689168,115,399251,148,196300,527,444374,294,117414,411,527128,126,437148,149,264
CFO
1.17b
+129.85%
66,368,200-16,326,600145,424,411205,505,148193,205,003337,602,602316,635,616744,403,4071,190,602,9081,024,411,007508,975,0861,169,900,367
Dividend
Jun 12, 20261.27 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yunnan Jianzhijia Health-Chain Co., Ltd. operates a significant pharmaceutical retail enterprise throughout China. This company oversees an extensive chain of roughly 1,200 proprietary stores, complemented by its digital pharmacy platform. Shoppers can find a broad spectrum of items, encompassing household medications, vision care products like contact lenses and their solutions, various medical devices, sexual wellness goods, nutritional supplements, traditional Chinese herbal medicines, personal hygiene articles, infant products, and even ready-to-eat convenience foods. Established in Kunming, China, in 2004, the company maintains its headquarters there.
IPO date
Dec 01, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT